Washington, D.C. 20549

Form 8-K


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event Reported): July 25, 2018  

(Exact Name of Registrant as Specified in Charter)

(State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification Number)


1275 Market Street, San Francisco, CA 94103-1410
(Address of Principal Executive Offices) (Zip Code)

(415) 558-0200
(Registrant's telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 [   ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 [   ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 [   ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 [   ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company [   ]


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [   ]


Item 2.02. Results of Operations and Financial Condition.

The following information is intended to be furnished under Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

On July 25, 2018, Dolby Laboratories, Inc. (the “Company”) issued a press release announcing its financial results for its fiscal quarter ended June 29, 2018. The full text of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference.  

Item 8.01. Other Events.

Declaration of Dividend

On July 25, 2018, the Company announced a cash dividend of $0.16 per share of Class A and Class B Common Stock, payable on August 14, 2018 to stockholders of record as of the close of business on August 6, 2018.  

Increase in Share Repurchase Authorization

On July 25, 2018, the Company also announced that its Board of Directors approved increasing the size of its stock repurchase program by $350 million, bringing the amount available for future repurchases of the Company’s Class A Common Stock to approximately $412 million. Stock repurchases under this program may be made through open market transactions, negotiated purchases or otherwise, at times and in such amounts as the Company considers appropriate. The timing of repurchases and the number of shares repurchased will depend on a variety of factors including price, the rate of dilution from the Company's equity compensation programs, regulatory requirements, and other market conditions. The Company may limit, suspend, or terminate the stock repurchase program at any time without prior notice. Any shares repurchased under the program will be returned to the status of authorized, but unissued shares of Class A Common Stock.

Disclosure Channels to Disseminate Information

The Company disseminates information to the public about the Company, its products, services and other matters through various channels, including the Company’s website (www.dolby.com), investor relations website (http://investor.dolby.com), SEC filings, press releases, public conference calls and webcasts, in order to achieve broad, non-exclusionary distribution of information to the public.  The Company encourages investors and others to review the information it makes public through these channels, as such information could be deemed to be material information.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description
99.1 Press Release of Dolby Laboratories, Inc. dated July 25, 2018


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 25, 2018By: /s/ Lewis Chew        
  Lewis Chew
  Executive Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)



Exhibit Number Description
99.1 Press Release of Dolby Laboratories, Inc. dated July 25, 2018



Dolby Laboratories Reports Third Quarter Fiscal 2018 Financial Results

SAN FRANCISCO, July 25, 2018 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the Company's financial results for the third quarter (Q3) of fiscal 2018. For the third quarter, Dolby reported total revenue of $317.4 million, compared to $305.7 million for the third quarter of fiscal 2017.

“We continue to see progress on several fronts,” said Kevin Yeaman, President and CEO, Dolby Laboratories.  “Apple adopted Dolby Atmos into Apple TV 4K while Microsoft announced Dolby Vision support for Xbox One.  We also now have partners that will be launching Dolby Cinema sites for the first time in England, Germany and Kuwait.”

Third quarter GAAP net income was $83.1 million, or $0.78 per diluted share, compared to net income of $76.0 million, or $0.73 per diluted share, for the third quarter of fiscal 2017. On a non-GAAP basis, third quarter net income was $98.9 million, or $0.92 per diluted share, compared to $89.2 million, or $0.86 per diluted share, for the third quarter of fiscal 2017. Dolby's non-GAAP measures are described and reconciled to the corresponding GAAP measures at the end of this release.


Today, Dolby announced a cash dividend of $0.16 per share of Class A and Class B common stock, payable on August 14, 2018, to stockholders of record as of the close of business on August 6, 2018.

Stock Repurchase Program

Today, Dolby also announced that its Board of Directors has approved increasing the size of its stock repurchase program by $350 million, bringing the amount available for future repurchases of the Company's Class A Common Stock to approximately $412 million. Stock repurchases under this program may be made through open market transactions, negotiated purchases, or otherwise, at times and in such amounts as the Company considers appropriate.

Financial Outlook

Q4 Fiscal 2018

Dolby is providing the following estimates for its fourth quarter (Q4) of fiscal 2018:

Fiscal Year 2018

Dolby is providing the following estimates for its fiscal 2018:

Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss Q3 fiscal 2018 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Wednesday, July 25, 2018. Access to the teleconference will be available over the Internet from http://investor.dolby.com/events.cfm or by dialing 1-866-548-4713. International callers can access the conference call at 1-323-794-2093.

A replay of the call will be available from 5:00 p.m. PT on Wednesday, July 25, 2018, until 9:00 p.m. PT on Wednesday, August 1, 2018, by dialing 1-844-512-2921 (international callers can access the replay by dialing 1-412-317-6671) and entering the confirmation code 1349902. An archived version of the teleconference will also be available on the Dolby Laboratories website, http://investor.dolby.com/events.cfm.

Non-GAAP Financial Information

To supplement Dolby's financial statements presented on a GAAP basis, Dolby provides certain non-GAAP financial measures to provide investors with an additional tool to evaluate Dolby's operating results in a manner that focuses on what Dolby's management believes to be its ongoing business operations. Specifically, we exclude the following as adjustments from one or more of our non-GAAP financial measures:

Stock-based compensation expense:  Stock-based compensation, unlike cash-based compensation, utilizes subjective and complex assumptions in the methodologies used to value the various stock-based award types that we grant. These assumptions may differ from those used by other companies. To facilitate more meaningful comparisons between our underlying operating results and those of other companies, we exclude stock-based compensation expense.

Amortization of acquisition-related intangibles:  We amortize intangible assets acquired in connection with acquisitions. These intangible assets consist of patents and technology, customer relationships, and other intangibles. We record amortization charges relating to these intangible assets in our GAAP financial statements, and we view these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of our acquisitions. As these amortization charges do not directly correlate to our operations during any particular period, and often remain unchanged between reporting periods, we exclude these charges to facilitate an evaluation of our current operating results and comparisons to our past operating performance.

Restructuring charges:  Restructuring charges are costs associated with a formal restructuring plan and primarily relate to employee severance benefits and asset impairments. We exclude restructuring costs, including any adjustments to charges recorded in prior periods, as we believe that these costs are not representative of our normal operating activities and therefore, excluding these amounts enables a more effective comparison to our past operating performance.

Income tax adjustments:  We believe that excluding the income tax effect of the aforementioned non-GAAP adjustments provides a more accurate view of our underlying operating results to management and investors.

Impact from U.S Tax Cuts and Jobs Act (Tax Reform):  The enactment of Tax Reform requires estimates based on Dolby's current understanding of the new tax laws. These charges are the result of a discrete and infrequent event that are not representative of current operating results and therefore, excluding these amounts enables a more effective comparison to our past operating performance.

Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby's management believes it is useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby's business. Dolby's management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above. Investors are also encouraged to review Dolby's GAAP financial statements as reported in its US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby Laboratories investor relations website, http://investor.dolby.com.

Forward-Looking Statements

Certain statements in this press release, including, but not limited to, statements relating to Dolby's expected financial results for Q4 fiscal 2018 and fiscal 2018, our ability to advance our long-term objectives and future dividend payments are "forward-looking statements" that are subject to risks and uncertainties. These forward-looking statements are based on management's current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those projected. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: risks associated with trends in the markets in which Dolby operates, including the Broadcast, PC, Consumer Electronics, Mobile, Cinema, and Other Markets; the loss of, or reduction in sales by, a key customer or licensee; pricing pressures; risks associated with the rate at which OEMs include optical disc playback in Windows® devices and the rate of consumer adoption of Windows operating systems; risks that a shift from disc-based media to online media content could result in fewer devices with Dolby® technologies; risks associated with the effects of macroeconomic conditions, including trends in consumer spending; risks relating to the expiration of patents; the timing of Dolby's receipt of royalty reports and payments from its licensees, including back payments; the impact of Tax Reform; the impact of changes in revenue recognition standards; timing of revenue recognition under licensing agreements and other contractual arrangements; Dolby's ability to develop, maintain, and strengthen relationships with industry participants; Dolby's ability to develop and deliver innovative technologies in response to new and growing markets; competitive risks; risks associated with conducting business in China and other countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the health of the motion picture industry generally; Dolby's ability to increase its revenue streams and to expand its business generally, and to expand its business beyond audio technologies to other technologies; risks associated with acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolby's SEC filings and reports, including the risks identified under the section captioned "Risk Factors" in its most recent annual report on Form 10-K. Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

About Dolby Laboratories

Dolby Laboratories (NYSE:DLB) is based in San Francisco with offices in over 20 countries around the globe. Dolby transforms the science of sight and sound into spectacular experiences. Through innovative research and engineering, we create breakthrough experiences for billions of people worldwide through a collaborative ecosystem spanning artists, businesses, and consumers. The experiences people have - in Dolby Vision, Dolby Atmos, Dolby Cinema, Dolby Voice, and Dolby Audio - revolutionize entertainment and communications at the cinema, on the go, in the home, and at work.

Dolby, Dolby Atmos, Dolby Audio, Dolby Cinema, Dolby Vision, Dolby Voice, and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories, Inc. in the Unites States and/or other countries. Other trademarks remain the property of their respective owners. DLB-F

(in thousands, except per share amounts; unaudited)

 Fiscal Quarter Ended Fiscal Year-To-Date Ended
 June 29,
June 30,
 June 29,
June 30,
Licensing$286,325 $278,106  $817,484 $752,422 
Products26,265 22,569  73,863 71,493 
Services4,857 4,990  15,252 15,491 
Total revenue317,447 305,665  906,599 839,406 
Cost of revenue:     
Cost of licensing12,111 12,711  31,980 29,628 
Cost of products17,213 14,910  49,851 46,618 
Cost of services5,141 4,504  14,469 12,823 
Total cost of revenue34,465 32,125  96,300 89,069 
Gross margin282,982 273,540  810,299 750,337 
Operating expenses:     
Research and development60,357 59,631  176,294 175,490 
Sales and marketing79,834 73,480  224,002 220,275 
General and administrative48,081 44,497  147,113 129,290 
Restructuring credits(82)  (446) 
Total operating expenses188,190 177,608  546,963 525,055 
Operating income94,792 95,932  263,336 225,282 
Other income/expense:     
Interest income5,488 2,511  13,161 6,511 
Interest expense(87)(31) (151)(94)
Other income/(expense), net(3,603)(2,109) (5,439)(1,546)
Total other income1,798 371  7,571 4,871 
Income before income taxes96,590 96,303  270,907 230,153 
Provision for income taxes(13,302)(20,117) (198,332)(49,666)
Net income including controlling interest83,288 76,186  72,575 180,487 
Less: net (income) attributable to controlling interest(143)(143) (421)(480)
Net income attributable to Dolby Laboratories, Inc.$83,145 $76,043  $72,154 $180,007 
Net income per share:     
Basic$0.80 $0.75  $0.70 $1.77 
Diluted$0.78 $0.73  $0.67 $1.73 
Weighted-average shares outstanding:     
Basic103,836 101,905  103,386 101,725 
Diluted106,950 104,222  106,943 103,986 

(in thousands; unaudited)

 June 29,
September 29,
Current assets:  
Cash and cash equivalents$829,621 $627,017 
Restricted cash7,842 7,351 
Short-term investments195,284 247,757 
Accounts receivable, net149,582 73,750 
Inventories23,932 25,051 
Prepaid expenses and other current assets32,672 30,508 
Total current assets1,238,933 1,011,434 
Long-term investments243,179 314,364 
Property, plant and equipment, net502,041 485,275 
Intangible assets, net185,140 189,648 
Goodwill314,317 311,087 
Deferred taxes143,949 190,915 
Other non-current assets42,260 30,831 
Total assets$2,669,819 $2,533,554 
Current liabilities:  
Accounts payable$16,970 $14,373 
Accrued liabilities197,076 207,034 
Income taxes payable4,830 1,216 
Deferred revenue21,436 23,150 
Total current liabilities240,312 245,773 
Long-term deferred revenue37,775 36,425 
Other non-current liabilities203,813 107,514 
Total liabilities481,900 389,712 
Stockholders’ equity:  
Class A common stock60 58 
Class B common stock43 43 
Additional paid-in capital89,077 61,331 
Retained earnings2,105,621 2,083,063 
Accumulated other comprehensive (loss)(13,301)(7,753)
Total stockholders’ equity – Dolby Laboratories, Inc.2,181,500 2,136,742 
Controlling interest6,419 7,100 
Total stockholders’ equity2,187,919 2,143,842 
Total liabilities and stockholders’ equity$2,669,819 $2,533,554 

(in thousands; unaudited)

 Fiscal Year-To-Date Ended
 June 29,
June 30,
Operating activities:  
Net income including controlling interest$72,575 $180,487 
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation and amortization61,398 64,543 
Stock-based compensation53,476 48,940 
Amortization of premium on investments2,046 2,077 
Provision for doubtful accounts2,653 1,167 
Deferred income taxes47,145 (11,446)
Other non-cash items affecting net income5,147 2,547 
Changes in operating assets and liabilities:  
Accounts receivable(78,480)(7,576)
Prepaid expenses and other assets(13,719)(10,657)
Accounts payable and other liabilities(12,781)14,877 
Income taxes, net102,422 19,033 
Deferred revenue(366)(560)
Other non-current liabilities(537)773 
Net cash provided by operating activities240,471 297,365 
Investing activities:  
Purchases of investment securities(151,585)(204,447)
Proceeds from sales of investment securities72,090 36,579 
Proceeds from maturities of investment securities194,038 126,199 
Purchases of PP&E(54,869)(81,668)
Payments for business acquisitions, net of cash acquired(6,563) 
Purchase of intangible assets(12,543)(5,250)
Change in restricted cash(491)(2,542)
Net cash provided by (used in) investing activities40,077 (131,129)
Financing activities:  
Proceeds from issuance of common stock85,941 47,765 
Repurchase of common stock(90,480)(74,994)
Payment of cash dividend(49,596)(42,768)
Distribution to controlling interest(1,022)(2,094)
Shares repurchased for tax withholdings on vesting of restricted stock(21,189)(16,875)
Net cash used in financing activities(76,346)(88,966)
Effect of foreign exchange rate changes on cash and cash equivalents(1,598)(766)
Net increase in cash and cash equivalents202,604 76,504 
Cash and cash equivalents at beginning of period627,017 516,112 
Cash and cash equivalents at end of period$829,621 $592,616 

GAAP to Non-GAAP Reconciliations
(in millions, except per share data); unaudited
The following tables present Dolby's GAAP financial measures reconciled to the non-GAAP financial measures included in this release for the third quarter of fiscal 2018 and 2017:
Net income:Fiscal Quarter Ended
 June 29,
June 30,
GAAP net income$83.1 $76.0 
Stock-based compensation17.1 15.7 
Amortization of acquisition-related intangibles2.0 2.6 
Restructuring credits, net(0.1) 
Income tax adjustments(3.2)(5.1)
Non-GAAP net income$98.9 $89.2 
Diluted earnings per share:Fiscal Quarter Ended
 June 29,
June 30,
GAAP diluted earnings per share$0.78 $0.73 
Stock-based compensation0.15 0.16 
Amortization of acquisition-related intangibles0.02 0.02 
Restructuring charges, net  
Income tax adjustments(0.03)(0.05)
Non-GAAP diluted earnings per share$0.92 $0.86 
Shares used in computing diluted earnings per share107 104 
The following tables present a reconciliation between GAAP and non-GAAP versions of the estimated financial amounts for the fourth quarter of fiscal 2018 and fiscal year 2018 included in this release:
Gross margin:Q4 2018Fiscal 2018
GAAP gross margin (low - high end of range)  86%   88%  
Stock-based compensation0.2% 0.2% 
Amortization of acquisition-related intangibles0.8% 0.8% 
Non-GAAP gross margin (low - high end of range) 87%   89%  
Operating expenses:Q4 2018Fiscal 2018
GAAP operating expenses (low - high end of range) $195 - $199   $744 - $748  
Stock-based compensation(18.0)(71.0)
Amortization of acquisition-related intangibles(1.0)(3.0)
Non-GAAP operating expenses (low - high end of range) $176 - $180   $670 - $674  
Diluted earnings per share:Q4 2018
GAAP diluted earnings per share$0.25 $0.31 
Stock-based compensation0.17 0.17 
Amortization of acquisition-related intangibles0.02 0.02 
Income tax adjustments(0.04)(0.04)
Non-GAAP diluted earnings per share$0.40 $0.46 
Shares used in computing diluted earnings per share107 107 

Investor Contact:
Elena Carr
Dolby Laboratories

Media Contact:
Tony Carter
Dolby Laboratories